X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-09-19 | PASG | Orbimed Advisors LLC | 10% | S - Sale | $0.71 | -39,300 | 7,794,569 | -1% | -$27,903 | ||||||
M | 2024-09-16 | PASG | Orbimed Advisors LLC | 10% | S - Sale | $0.73 | -200,131 | 7,833,869 | -2% | -$146,727 | |||||
D | 2024-02-13 | PASG | Borthwick Kathleen | SVP, Interim CFO | S - Sale+OE | $0.97 | -1,470 | 28,466 | -5% | -$1,426 | |||||
D | 2024-02-13 | PASG | Forman Mark S | Chief Medical Officer | S - Sale+OE | $0.97 | -1,638 | 48,631 | -3% | -$1,589 | |||||
D | 2024-01-02 | PASG | Forman Mark S | Chief Medical Officer | S - Sale+OE | $0.91 | -15,813 | 45,269 | -26% | -$14,390 | |||||
D | 2024-01-02 | PASG | Borthwick Kathleen | SVP, Interim CFO | S - Sale+OE | $0.91 | -10,672 | 25,936 | -29% | -$9,712 | |||||
D | 2024-01-02 | PASG | Cale Edgar B. | GC, Corporate Secretary | S - Sale+OE | $0.91 | -15,813 | 45,995 | -26% | -$14,390 | |||||
D | 2023-07-28 | PASG | King Simona | CFO | S - Sale+OE | $0.88 | -11,453 | 23,994 | -32% | -$10,079 | |||||
M | 2023-06-27 | PASG | Orbimed Advisors LLC | 10% | P - Purchase | $0.84 | +1,192,577 | 8,034,000 | +17% | +$1,001,765 | |||||
D | 2023-06-16 | PASG | Fotopoulos Alexandros | Chief Technical Officer | S - Sale+OE | $0.93 | -4,052 | 28,693 | -12% | -$3,778 | |||||
D | 2023-04-18 | PASG | King Simona | CFO | S - Sale+OE | $1.05 | -2,053 | 2,053 | -50% | -$2,156 | |||||
2022-12-01 | PASG | Kapadia Sandip | Dir | S - Sale | $1.19 | -5,000 | 0 | -100% | -$5,965 |
A | Amended filing |
D | Derivative transaction in filing (usually option exercise) |
E | Error detected in filing |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |